Author:
Zhang Hua,Tang Wei-Lun,Kheirolomoom Azadeh,Fite Brett Z.,Wu Bo,Lau Kenneth,Baikoghli Mo,Raie Marina Nura,Tumbale Spencer K.,Foiret Josquin,Ingham Elizabeth S.,Mahakian Lisa M.,Tam Sarah M.,Cheng R. Holland,Borowsky Alexander D.,Ferrara Katherine W.
Funder
National Cancer Institute
Reference80 articles.
1. FDA Approves Atezolizumab for PD-L1 Positive Unresectable Locally Advanced or Metastatic Triple-negative Breast Cancer,2019
2. Toll-like receptors and their ligands;Barton;Curr. Top. Microbiol. Immunol.,2002
3. Resiquimod as an immunologic adjuvant for NY-ESO-1 protein vaccination in patients with high-risk melanoma;Sabado;Cancer Immunol. Res.,2015
4. Current clinical trials testing the combination of immunotherapy with radiotherapy;Kang;J. ImmunoTher. Cancer,2016
Cited by
38 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献